1-3 of 3
Danijela Dokic, MD
Close
Sort by
Journal Articles

Hypoxia Inducible Factor 1á (HIF-1á) Regulates CD20 Expression in Lymphoma Cells: Possible Implications for Rituximab Based Therapy in Diffuse Large B Cell Lymphoma (DLBCL).

Sairah Ahmed, MD, Andrew M. Evens, DO, MSc, Savita Bhalla, PhD, Amareshwar Singh, PhD, Crystal James, Shuo Yang, PhD, Sheila Prachand, Danijela Dokic, MD, Randy D. Gascoyne, MD, Jane N. Winter, MD, Paul T Schumacker, PhD, Leo I. Gordon, MD
Journal: Blood
Blood (2009) 114 (22): 1698.
https://doi.org/10.1182/blood.V114.22.1698.1698
Published: 2009
Journal Articles

PX-478, a Novel Small Molecule Inhibitor of Hypoxia Inducible Factor-1 (HIF-1) Downregulates HIF and Induces Cytotoxicity in Diffuse Large B Cell Lymphoma Cells.

Savita Bhalla, PhD, Leo I. Gordon, MD, Amareshwar Singh, PhD, Sairah Ahmed, MD, Danijela Dokic, MD, Crystal James, Paul T Schumacker, PhD, Andrew M Evens, DO, MSc
Journal: Blood
Blood (2009) 114 (22): 2713.
https://doi.org/10.1182/blood.V114.22.2713.2713
Published: 2009
Journal Articles

Hypoxia-Inducible Factor-Alpha (HIF-α) Activation in Non-Hodgkin’s Lymphoma (NHL): Relationship to the Thioredoxin Family and Correlation with Survival by Tissue Microarray (TMA).

Andrew M. Evens, DO, MS, Paul T. Schumacker, PhD, Irene B. Helenowski, MS, Amar Singh, PhD, Danijela Dokic, MD, Anjeni Keswani, MD, Elizabeth Kordeluk, BS, Adekunle Raji, MS, Jane N. Winter, MD, Borko D. Jovanovic, PhD, Arne Holmgren, MD, PhD, Beverly P. Nelson, MD, Leo I. Gordon, MD
Journal: Blood
Blood (2007) 110 (11): 3587.
https://doi.org/10.1182/blood.V110.11.3587.3587
Published: 2007